By interacting with endothelial cells that constitute the BBB, microbial metabolites (e.g., SCFAs) can regulate the expression of tight junction (TJ) proteins, thereby enhancing barrier function
This technology is particularly beneficial for patients with metabolic diseases who require continuous management
Phospholipase C signaling via the parathyroid hormone (PTH)/PTH-related peptide receptor is essential for normal bone responses to PTH
The technique is also being investigated for its potential benefits in various neuropsychiatric disorders such as autism, Parkinsons disease, Alzheimers disease, and multiple sclerosis, although the outcomes of these studies remain uncertain [157,158,159]
S., Mani, H., et al
Reach out to us using any of the methods below, and a member of our team will be in touch with you shortly